Eli Lilly Unveils Affordable Access to Zepbound for Weight Loss
In a groundbreaking move aimed at expanding access to weight loss solutions, Eli Lilly has announced a significant reduction in the prices of its popular medication, Zepbound. This innovative approach is set to revolutionize the way patients can obtain this highly sought-after drug, which has garnered attention for its effectiveness in weight management.
Through its self-pay channel, LillyDirect®, Eli Lilly is now offering single-dose vials of Zepbound at prices that are at least 50% lower tha...